Kardigan, Inc. (KARD)
NASDAQ: KARD · Real-Time Price · USD
12.97
-1.38 (-9.62%)
At close: Oct 13, 2026, 4:00 PM EDT
12.97
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:10 PM EDT
Kardigan Earnings Call Transcripts
Fiscal Year 2026
-
A platform-focused cardiovascular innovator highlighted its late-stage pipeline in genetic cardiomyopathy and aortic stenosis, leveraging adaptive trial designs and real-world data integration. Key programs danicamtiv and ataciguat are advancing through pivotal trials, with major data readouts expected next year.